We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00564512
Recruitment Status : Completed
First Posted : November 28, 2007
Last Update Posted : July 25, 2013
Information provided by (Responsible Party):
French Innovative Leukemia Organisation